• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HMMR 通过使吞噬细胞的杀伤作用失活来触发肝细胞癌的免疫逃逸。

HMMR triggers immune evasion of hepatocellular carcinoma by inactivation of phagocyte killing.

机构信息

Department of Oncology & Cancer Institute, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, P. R. China.

Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, P. R. China.

出版信息

Sci Adv. 2024 Jun 7;10(23):eadl6083. doi: 10.1126/sciadv.adl6083. Epub 2024 Jun 5.

DOI:10.1126/sciadv.adl6083
PMID:38838151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11152120/
Abstract

Hepatocellular carcinoma (HCC) acquires an immunosuppressive microenvironment, leading to unbeneficial therapeutic outcomes. Hyaluronan-mediated motility receptor (HMMR) plays a crucial role in tumor progression. Here, we found that aberrant expression of HMMR could be a predictive biomarker for the immune suppressive microenvironment of HCC, but the mechanism remains unclear. We established an HMMR liver cancer mouse model to elucidate the HMMR-mediated mechanism of the dysregulated "don't eat me" signal. HMMR knockout inhibited liver cancer growth and induced phagocytosis. HMMR liver cancer cells escaped from phagocytosis via sustaining CD47 signaling. Patients with HMMRCD47 expression showed a worse prognosis than those with HMMRCD47 expression. HMMR formed a complex with FAK/SRC in the cytoplasm to activate NF-κB signaling, which could be independent of membrane interaction with CD44. Notably, targeting HMMR could enhance anti-PD-1 treatment efficiency by recruiting CD8 T cells. Overall, our data revealed a regulatory mechanism of the "don't eat me" signal and knockdown of HMMR for enhancing anti-PD-1 treatment.

摘要

肝细胞癌 (HCC) 获得免疫抑制微环境,导致治疗效果不佳。透明质酸介导的运动受体 (HMMR) 在肿瘤进展中起着至关重要的作用。在这里,我们发现 HMMR 的异常表达可能是 HCC 免疫抑制微环境的预测性生物标志物,但机制尚不清楚。我们建立了 HMMR 肝癌小鼠模型,以阐明失调的“别吃我”信号的 HMMR 介导机制。HMMR 敲除抑制肝癌生长并诱导吞噬作用。HMMR 肝癌细胞通过维持 CD47 信号逃避吞噬作用。与 HMMRCD47 表达的患者相比,HMMRCD47 表达的患者预后更差。HMMR 在细胞质中与 FAK/SRC 形成复合物以激活 NF-κB 信号,该信号可能独立于与 CD44 的膜相互作用。值得注意的是,靶向 HMMR 可以通过招募 CD8 T 细胞来增强抗 PD-1 治疗的效果。总体而言,我们的数据揭示了“别吃我”信号的调节机制以及敲低 HMMR 增强抗 PD-1 治疗的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/999443c86a6e/sciadv.adl6083-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/d8fc47ba99bf/sciadv.adl6083-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/3b0679a9925a/sciadv.adl6083-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/cb003e96a04e/sciadv.adl6083-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/628fd72a6ff9/sciadv.adl6083-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/4223744d92b3/sciadv.adl6083-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/23bf2ad7197d/sciadv.adl6083-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/1c3482154a3f/sciadv.adl6083-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/999443c86a6e/sciadv.adl6083-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/d8fc47ba99bf/sciadv.adl6083-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/3b0679a9925a/sciadv.adl6083-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/cb003e96a04e/sciadv.adl6083-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/628fd72a6ff9/sciadv.adl6083-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/4223744d92b3/sciadv.adl6083-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/23bf2ad7197d/sciadv.adl6083-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/1c3482154a3f/sciadv.adl6083-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb3/11152120/999443c86a6e/sciadv.adl6083-f8.jpg

相似文献

1
HMMR triggers immune evasion of hepatocellular carcinoma by inactivation of phagocyte killing.HMMR 通过使吞噬细胞的杀伤作用失活来触发肝细胞癌的免疫逃逸。
Sci Adv. 2024 Jun 7;10(23):eadl6083. doi: 10.1126/sciadv.adl6083. Epub 2024 Jun 5.
2
SIRPα blockade therapy potentiates immunotherapy by inhibiting PD-L1 myeloid cells in hepatocellular carcinoma.信号调节蛋白α(SIRPα)阻断疗法通过抑制肝细胞癌中程序性死亡配体1(PD-L1)髓系细胞来增强免疫疗法。
Cell Death Dis. 2025 Jun 16;16(1):451. doi: 10.1038/s41419-025-07779-7.
3
Matrix stiffness-dependent PD-L2 deficiency improves SMYD3/xCT-mediated ferroptosis and the efficacy of anti-PD-1 in HCC.基质硬度依赖性PD-L2缺陷改善SMYD3/xCT介导的铁死亡及抗PD-1在肝癌中的疗效。
J Adv Res. 2025 Jul;73:265-282. doi: 10.1016/j.jare.2024.08.021. Epub 2024 Aug 17.
4
Suppression of Hepatocellular Carcinoma by Deletion of SIRT2 in Hepatocytes via Elevated C/EBPβ/GADD45γ.通过升高C/EBPβ/GADD45γ,肝细胞中SIRT2缺失抑制肝细胞癌
Cell Mol Gastroenterol Hepatol. 2025;19(7):101494. doi: 10.1016/j.jcmgh.2025.101494. Epub 2025 Mar 11.
5
Role of CD28 PD-1 Tc cells in immune response and prognosis prediction in hepatocellular carcinoma.CD28、程序性死亡受体1(PD-1)阳性T细胞在肝细胞癌免疫反应及预后预测中的作用
Front Immunol. 2025 Jun 4;16:1576193. doi: 10.3389/fimmu.2025.1576193. eCollection 2025.
6
The impact of de novo lipogenesis on predicting survival and clinical therapy: an exploration based on a multigene prognostic model in hepatocellular carcinoma.从头脂肪生成对预测生存和临床治疗的影响:基于肝细胞癌多基因预后模型的探索
J Transl Med. 2025 Jun 18;23(1):679. doi: 10.1186/s12967-025-06704-y.
7
High-expression of BCL10 inhibits cell-mediated immunity within the tumor immune microenvironment.BCL10的高表达抑制肿瘤免疫微环境中的细胞介导免疫。
Front Immunol. 2025 Jun 5;16:1616321. doi: 10.3389/fimmu.2025.1616321. eCollection 2025.
8
Hepatoma-Derived Growth Factor Promotes Liver Carcinogenesis by Inducing Phosphatase and Tensin Homolog Inactivation.肝癌衍生生长因子通过诱导磷酸酶和张力蛋白同源物失活促进肝癌发生。
Lab Invest. 2025 Jun;105(6):104127. doi: 10.1016/j.labinv.2025.104127. Epub 2025 Mar 11.
9
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.早期和极早期肝细胞癌的消融和非手术治疗:系统评价和网络荟萃分析。
Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221.
10
Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.Fbxw7通过Notch1信号通路调控肝细胞癌的迁移和侵袭。
Int J Oncol. 2015 Jul;47(1):231-43. doi: 10.3892/ijo.2015.2981. Epub 2015 May 4.

引用本文的文献

1
Identifying key genes involved in HBV-related hepatocellular carcinoma: diagnose, prognosis, interaction and immune analysis.鉴定与乙肝相关肝细胞癌有关的关键基因:诊断、预后、相互作用及免疫分析
Discov Oncol. 2025 Aug 9;16(1):1510. doi: 10.1007/s12672-025-03320-6.
2
Macrophage Membrane-Coated Liposomes Delivering Vonoprazan Disrupt Mitochondrial Oxidative Phosphorylation in Diffuse Large B-Cell Lymphoma.巨噬细胞膜包被的递送沃克帕唑的脂质体破坏弥漫性大B细胞淋巴瘤中的线粒体氧化磷酸化。
Int J Nanomedicine. 2025 Jun 24;20:8063-8083. doi: 10.2147/IJN.S520567. eCollection 2025.
3
Development of a MVI associated HCC prognostic model through single cell transcriptomic analysis and 101 machine learning algorithms.

本文引用的文献

1
Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer.靶向透明质酸介导的运动受体 (HMMR) 可增强前列腺癌对雄激素受体信号抑制剂的反应。
Br J Cancer. 2023 Oct;129(8):1350-1361. doi: 10.1038/s41416-023-02406-8. Epub 2023 Sep 6.
2
Roles of macrophages in tumor development: a spatiotemporal perspective.巨噬细胞在肿瘤发展中的作用:时空视角。
Cell Mol Immunol. 2023 Sep;20(9):983-992. doi: 10.1038/s41423-023-01061-6. Epub 2023 Jul 10.
3
HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress-driven hepatocellular carcinoma progression.
通过单细胞转录组分析和101种机器学习算法开发与微血管侵犯相关的肝癌预后模型。
Sci Rep. 2025 Mar 7;15(1):7977. doi: 10.1038/s41598-025-91475-1.
4
N-methyladenosine Reader IGF2BP2-modified HMMR Promotes Non-small Cell Lung Cancer Metastasis via Interaction with MAP4K4.N-甲基腺苷阅读器IGF2BP2修饰的HMMR通过与MAP4K4相互作用促进非小细胞肺癌转移。
Int J Biol Sci. 2025 Jan 21;21(4):1391-1409. doi: 10.7150/ijbs.104097. eCollection 2025.
5
Deciphering the Molecular Complexity of Hepatocellular Carcinoma: Unveiling Novel Biomarkers and Therapeutic Targets Through Advanced Bioinformatics Analysis.解析肝细胞癌的分子复杂性:通过先进的生物信息学分析揭示新的生物标志物和治疗靶点。
Cancer Rep (Hoboken). 2024 Aug;7(8):e2152. doi: 10.1002/cnr2.2152.
HMMR 通过促进内质网应激驱动的肝癌进展过程中的自噬溶酶体活性来缓解内质网应激。
Cancer Commun (Lond). 2023 Sep;43(9):981-1002. doi: 10.1002/cac2.12464. Epub 2023 Jul 5.
4
Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.透明质酸介导运动受体 (RHAMM) 定义了与肿瘤进展相关的侵袭性生态位,并预测乳腺癌患者预后不良。
J Pathol. 2023 Jul;260(3):289-303. doi: 10.1002/path.6082. Epub 2023 Apr 26.
5
Emerging phagocytosis checkpoints in cancer immunotherapy.癌症免疫治疗中的新兴吞噬检查点。
Signal Transduct Target Ther. 2023 Mar 7;8(1):104. doi: 10.1038/s41392-023-01365-z.
6
Combinatorial targeting of immune checkpoints and epigenetic regulators for hepatocellular carcinoma therapy.用于肝细胞癌治疗的免疫检查点和表观遗传调节剂的联合靶向治疗
Oncogene. 2023 Mar;42(14):1051-1057. doi: 10.1038/s41388-023-02646-1. Epub 2023 Mar 1.
7
A timeline of tumour-associated macrophage biology.肿瘤相关巨噬细胞生物学的时间线。
Nat Rev Cancer. 2023 Apr;23(4):238-257. doi: 10.1038/s41568-022-00547-1. Epub 2023 Feb 15.
8
Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy.肝细胞癌中靶向肿瘤相关巨噬细胞:生物学、策略与免疫治疗
Cell Death Discov. 2023 Feb 15;9(1):65. doi: 10.1038/s41420-023-01356-7.
9
HMMR promotes prostate cancer proliferation and metastasis via AURKA/mTORC2/E2F1 positive feedback loop.HMMR通过AURKA/mTORC2/E2F1正反馈回路促进前列腺癌的增殖和转移。
Cell Death Discov. 2023 Feb 7;9(1):48. doi: 10.1038/s41420-023-01341-0.
10
Protocol for detecting macrophage-mediated cancer cell phagocytosis in vitro and in vivo.体外和体内检测巨噬细胞介导的癌细胞吞噬作用的方案。
STAR Protoc. 2023 Mar 17;4(1):101940. doi: 10.1016/j.xpro.2022.101940. Epub 2022 Dec 14.